These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2807121)

  • 1. [Cardiac tachyarrhythmia--when should it be treated?].
    Lüderitz B
    Fortschr Med; 1989 Sep; 107(27):18. PubMed ID: 2807121
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug therapy of tachycardic ventricular arrhythmias].
    Höpp HW; Kochs M; Hilger HH
    Med Klin (Munich); 1988 Nov; 83(23):800-8. PubMed ID: 3062347
    [No Abstract]   [Full Text] [Related]  

  • 3. [When should heart failure be treated with anti-arrhythmia agents? Can the prognosis be improved?].
    Meinertz T
    Internist (Berl); 1990 Mar; 31(3 Suppl [ Anniv No TIARRH):12-4; discussion 14-5. PubMed ID: 1693602
    [No Abstract]   [Full Text] [Related]  

  • 4. [Reproducibility of ventricular arrhythmias induced before and after drug therapy. Predictive value of their anti-arrhythmic effect].
    Frank R; Fontaine G; Coutte R; Tonet J; Cohen A; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():79-86. PubMed ID: 6803705
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of serious cardiac arrhythmias with drugs.
    Echt DS; Mason JW
    Cardiovasc Clin; 1984; 14(3):191-209. PubMed ID: 6426796
    [No Abstract]   [Full Text] [Related]  

  • 6. Supraventricular tachyarrhythmias. Treatment with edrophonium.
    Cantwell JD; Dawson JE; Fletcher GF
    Arch Intern Med; 1972 Aug; 130(2):221-4. PubMed ID: 5050557
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value and limitations of electropharmacological tests in the selection of anti-arrhythmic therapy in malignant ventricular tachyarrhythmia].
    Klein H
    Cardiologia; 1985 Jul; 30(7):487-92. PubMed ID: 3834995
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemodynamics in ventricular arrhythmias and in their treatment].
    Lüderitz B; Manz M
    Z Kardiol; 1988; 77 Suppl 5():143-9. PubMed ID: 3066036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term prognosis of chronic recurrent sustained ventricular tachycardia. Critical analysis of a prospective operative scheme followed since 1979 on 64 consecutive subjects. II].
    Naccarella F; Palmieri M; Barbato G; De Castro U; Bartoletti A; Guaragna RF; Lombardi G; Bracchetti D; Turba E; Abbati A
    Cardiologia; 1987 Mar; 32(3):315-27. PubMed ID: 3607802
    [No Abstract]   [Full Text] [Related]  

  • 10. PVCs in the elderly: when should they be treated?
    Cooper MW
    Geriatrics; 1983 Jun; 38(6):69-77. PubMed ID: 6189766
    [No Abstract]   [Full Text] [Related]  

  • 11. [Electrophysiologic effects of anti-arrhythmia agents. Their predictive value of therapeutic effects].
    Lévy S
    Arch Mal Coeur Vaiss; 1981 Dec; 74 Spec No():29-35. PubMed ID: 6803700
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sustained ventricular tachycardia: epidemiological, clinical and prognostic aspects. Long-term follow up of different subgroups of patients under anti-arrhythmia therapy. I].
    Naccarella F; Palmieri M; Nanni G; Barbato G; Casella G; Bartoletti A; Bracchetti D
    Cardiologia; 1987 Jan; 32(1):55-64. PubMed ID: 3581116
    [No Abstract]   [Full Text] [Related]  

  • 13. [Protocol of the serial electropharmacological study for selecting the most efficacious chronic anti-arrhythmia therapy in patients with sustained recurrent ventricular tachycardia and in survivors of cardiac arrest secondary to ventricular tachycardia].
    Raviele A; Di Pede F; Piccolo E
    G Ital Cardiol; 1985 Mar; 15(3):354-7. PubMed ID: 4018479
    [No Abstract]   [Full Text] [Related]  

  • 14. [The value of electrophysiological studies in the treatment of ventricular tachycardias with amiodarone alone or in combination with class-I anti-arrhythmia drugs].
    Bellocci F; Santarelli P; Montenero S; Nobile A; Spampinato A; Nava S; Zecchi P; Manzoli U
    Cardiologia; 1988 Apr; 33(4):399-405. PubMed ID: 3409264
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ventricular tachyarrhythmia].
    Harumi K
    Nihon Naika Gakkai Zasshi; 1990 Sep; 79(9):1272-80. PubMed ID: 2258673
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical electrophysiology of ventricular tachycardia.
    Prystowsky EN; Heger JJ; Lloyd EA; Zipes DP
    Cardiol Clin; 1983 May; 1(2):253-73. PubMed ID: 6544638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Idiopathic ventricular tachycardia].
    Frabetti L; Capucci A; Silvani S; Orselli L; Magnani B
    Minerva Cardioangiol; 1985 Dec; 33(12):807-14. PubMed ID: 4094702
    [No Abstract]   [Full Text] [Related]  

  • 18. [Risks and rules in the use of anti-arrhythmia agents].
    Motté G; Sebag C
    Arch Mal Coeur Vaiss; 1981 Apr; 74(4):473-9. PubMed ID: 6786244
    [No Abstract]   [Full Text] [Related]  

  • 19. Lidocaine (Xylocaine) as an anti-arrhythmic agent.
    Med Lett Drugs Ther; 1971 Jan; 13(1):1-2. PubMed ID: 4104507
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new method for the evaluation of the success of anti-arrhythmic drug therapy and a paradoxical drug-induced arrhythmogenic effect in individual patients].
    Andresen D; von Leitner ER; Wegscheider K; Schröder R
    Z Kardiol; 1984 Aug; 73(8):492-7. PubMed ID: 6208699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.